Plain-English translation of NCT06648733 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a pharmacist reviewing your discharge medications before you leave the hospital can make your transition home safer and smoother. Researchers will check that the medications prescribed by your doctors are available in your area and can actually be prescribed by your regular doctor, then discuss any concerns with your care team. They'll also talk with patients and healthcare providers about their experiences to understand what works best.
When patients with serious illnesses move from hospital care to home care, medication mistakes sometimes happen — prescriptions may not be available locally, or doctors may not be able to prescribe them easily. This study aims to catch these problems before you leave the hospital so your care at home goes more smoothly.
You likely qualify if…
You likely don't qualify if…
If you're enrolled, a pharmacist from the hospital will review your discharge medications before you leave and check with your home care team and regular doctor to make sure everything is available and can be prescribed. You may also be invited to participate in focus group discussions where you can share your experience and thoughts about your medication transition. The study collects information from your medical records both before and after your discharge to track how the medication review process affects your care.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany
Sponsor
University Hospital Muenster
Collaborators
University Hospital Munich
Enrollment target
~200 participants
Started
June 2024
Primary completion
June 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christoph Klaas, Dr. rer. nat.
Pharmacy of the University Hospital Muenster
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.